| __timestamp | Galapagos NV | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 79838000 |
| Thursday, January 1, 2015 | 129714000 | 121816000 |
| Friday, January 1, 2016 | 139574000 | 117633000 |
| Sunday, January 1, 2017 | 218502000 | 4577000 |
| Monday, January 1, 2018 | 322876000 | 12670000 |
| Tuesday, January 1, 2019 | 427320000 | 12135000 |
| Wednesday, January 1, 2020 | 523667000 | 18942000 |
| Friday, January 1, 2021 | 1629000 | 32328000 |
| Saturday, January 1, 2022 | 12079000 | 44678000 |
| Sunday, January 1, 2023 | 35989000 | 65486000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, cost efficiency is a critical determinant of success. This analysis delves into the cost of revenue trends for PTC Therapeutics, Inc. and Galapagos NV from 2014 to 2023. Over this period, Galapagos NV exhibited a significant increase in cost of revenue, peaking in 2020 with a staggering 523% rise from its 2014 figures. In contrast, PTC Therapeutics, Inc. maintained a more stable trajectory, with a notable dip in 2017, where costs plummeted by 96% compared to the previous year. By 2023, PTC Therapeutics, Inc. had increased its cost efficiency, reducing its cost of revenue by approximately 46% from its 2015 peak. This data underscores the dynamic strategies employed by these companies in managing operational costs, offering valuable insights into their financial health and strategic priorities.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Galapagos NV
Cost of Revenue Trends: Pfizer Inc. vs PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for Zoetis Inc. and PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for GSK plc and Galapagos NV
Cost of Revenue Trends: United Therapeutics Corporation vs PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Galapagos NV
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Galapagos NV
Cost of Revenue: Key Insights for Halozyme Therapeutics, Inc. and PTC Therapeutics, Inc.
Halozyme Therapeutics, Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
PTC Therapeutics, Inc. vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Dyne Therapeutics, Inc.